🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety and efficacy of IFN-α c...
Status
Unknown
Location
The First Affiliated Hospital of Soochow University
Start Date
2019-04-01
Trial ID
NCT04534634
Treatments Being Tested
This is a phase I clinical study to evaluate the safety and efficacy of CAR...
Status
Unknown
Location
Shandong Second Provincial General Hospital
Start Date
2021-09-06
Trial ID
NCT05420493
Treatments Being Tested
MPM patients are not eligible for surgical procedures like decortication or...
Status
Completed
Location
University Hospital Zurich, Division of Oncology
Start Date
2015-02-19
Trial ID
NCT01722149
Treatments Being Tested
The CATARSIS study explores the use of anti-CD19 CAR T-cell therapy as a no...
Status
Recruiting
Location
Fondazione Policlinico Universitario A. Gemelli IRCCS
Start Date
2024-11-29
Trial ID
NCT06685042
Treatments Being Tested
Background: The National Cancer Institute (NCI) Surgery Branch has develop...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2014-02-07
Trial ID
NCT02111850
This phase I clinical trial evaluates the safety and feasibility of adminis...
Status
Terminated
Location
UCLA / Jonsson Comprehensive Cancer Center
Start Date
2017-07-26
Trial ID
NCT03240861
This is a first-in-human dose escalation/dose expansion study to evaluate t...
Status
Active Not Recruiting
Location
H Lee Moffitt Cancer Center and Research Institute
Start Date
2019-05-20
Trial ID
NCT03927261
Treatments Being Tested
The investigators propose a nonrandomized, Phase I study to assess the safe...
Status
Withdrawn
Location
Hammersmith Hospital
Start Date
2011-04
Trial ID
NCT01336478
RATIONALE: Placing a tumor antigen chimeric receptor that has been created ...
Status
Unknown
Location
Chinese PLA General Hospital
Start Date
2013-06
Trial ID
NCT01886976
Treatments Being Tested
Current treatments for relapsed/refractory hematopoietic malignancies such ...
Status
Unknown
Location
Multiple Locations
Start Date
2021-03
Trial ID
NCT04767308
Treatments Being Tested